The United European Gastroenterology Podcast
Flares, surgery and the postpartum period. Mette Julsgaard and Pradeep Mundre on whether active disease or a JAK inhibitor is the bigger risk, starting upadacitinib at 28 weeks, acute severe col...
Mette Julsgaard and Pradeep Mundre on IBD before and during pregnancy: what active disease costs in fertility, what to check at the preconception visit, and a drug by drug run through of what to...
Operate on every high-risk early oesophageal cancer after endoscopic resection and more than 80% of those patients gain nothing. Roos Pouw, Ana-Maria Bucalau and Jessie Elliott on strict endosco...
UEG Podcast is on summer holiday and re-releases published episodes that we think deserve another listen. Enjoy!
In this episode of the UEG Talks conversation between Maria Vehreschild a...
UEG Podcast is on summer holiday and re-releases published episodes that we think deserve another listen. Enjoy!
Functional gastrointestinal disorders, or disorder of gut-brain interacti...
UEG Podcast is on summer holiday and re-releases published episodes that we think deserve another listen. Enjoy!
In this episode, host Egle speaks with former UEG President Axel Dignass ...
Michael Bretthauer on the real epidemiology of colorectal cancer in the under-50s: a genuine rise from a tiny baseline, the carcinoid confounder inflating the numbers, lifestyle versus genetics,...
The 2024 MASLD treatment guidelines are already changing. Pradeep Mundre and Professor Sven Francque (Antwerp), guideline co-author, cover weight-loss targets (7% and 10%), resmetirom in F2-F3 f...
Around one in three adults has MASLD, but only a few percent reach cirrhosis. Pradeep Mundre and Professor Sven Francque (Antwerp), co-author of the 2024 EASL guidelines, cover the new nomenclat...
Sphincter-preserving surgery spares most rectal cancer patients a stoma, but hands many of them low anterior resection syndrome (LARS). Three European surgeons join Harald Rosen in discussing fo...